The chemical that triggers muscle contraction at the neuromuscular junction is ________.

Neurotransmitters are chemical messengers released from presynaptic terminals that transmit signals across synapses. Major types: Acetylcholine (ACh): NMJ (skeletal muscle), parasympathetic nervous system, CNS (basal forebrain). Amines: Noradrenaline/norepinephrine (sympathetic NS, CNS), Dopamine (reward, movement), Serotonin (mood, sleep), Histamine. Amino acids: GABA (major inhibitory), Glutamate (major excitatory), Glycine (inhibitory in spinal cord). Peptides: Endorphins, Substance P, oxytocin, vasopressin. Purines: ATP, adenosine. Gases: Nitric oxide (NO), Carbon monoxide. The neurotransmitter used depends on the type of synapse — acetylcholine is specifically and exclusively used at the neuromuscular junction for skeletal muscle.

The process linking the electrical signal (action potential) to the mechanical response (contraction) is called excitation-contraction (E-C) coupling. Key steps: The muscle action potential propagates along the sarcolemma (muscle cell membrane) and dips into the T-tubule system (transverse tubules — invaginations of the sarcolemma penetrating deep into the muscle fibre). Voltage-sensitive dihydropyridine receptors (DHPRs) in the T-tubule membrane detect the action potential and physically interact with ryanodine receptors (RyRs) in the adjacent sarcoplasmic reticulum (SR) membrane. RyRs open, releasing Ca²⁺ from the SR lumen into the cytoplasm. Ca²⁺ concentration in the cytoplasm rises from ~100 nM at rest to ~10 µM during activation. Ca²⁺ binds troponin C (TnC) — a calcium-sensitive protein in the troponin complex (which also includes troponin I and troponin T). Ca²⁺ binding causes tropomyosin to shift, uncovering myosin-binding sites on actin → cross-bridge cycling → contraction. After stimulation ends: Ca²⁺ pumped back into SR by SERCA (sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase) → Ca²⁺ concentration falls → tropomyosin re-covers actin sites → muscle relaxes.

The sarcomere is the fundamental contractile unit of skeletal muscle, bounded by Z-lines (Z-discs). Each sarcomere contains: Thick filaments (myosin): in the A-band (dark band in cross-striated muscle under light microscopy). Composed of many myosin II molecules, each with two globular heads and a long tail. The myosin heads are the molecular motors that interact with actin and hydrolyse ATP to generate force. Thin filaments (actin): extend from Z-lines into the A-band, forming I-bands (light bands) between A-bands. Decorated with tropomyosin (regulatory protein blocking myosin-binding sites at rest) and troponin complex (Ca²⁺-sensitive regulatory proteins). Titin: giant elastic protein connecting Z-line to M-line, provides passive elasticity. Nebulin: large protein running alongside actin filaments, regulates actin filament length. During contraction (sliding filament mechanism): thick and thin filaments slide past each other (neither shortens), Z-lines move toward each other → sarcomere shortens → I-bands and H-zone narrow → A-band width unchanged. This generates force and shortening of the muscle fibre.

Several important neurological and autoimmune diseases specifically target the NMJ. Myasthenia Gravis (MG): autoimmune disease where antibodies attack nicotinic AChRs at the motor end plate, reducing receptor availability → muscle weakness that worsens with activity and improves with rest. Characteristic: ptosis (drooping eyelid), diplopia, dysarthria, dysphagia, limb weakness. Treatment: acetylcholinesterase inhibitors (pyridostigmine), immunosuppression, thymectomy (thymus often enlarged in MG). Lambert-Eaton Myasthenic Syndrome (LEMS): autoimmune antibodies against voltage-gated Ca²⁺ channels (P/Q type) in the presynaptic terminal → reduced Ca²⁺ influx → less ACh released. Often paraneoplastic (associated with small cell lung cancer). Unlike MG, strength improves with repetitive stimulation. Botulism: Clostridium botulinum toxin (BTX) cleaves SNARE proteins (specifically SNAP-25 or synaptobrevin) required for ACh vesicle fusion with presynaptic membrane → ACh cannot be released → descending flaccid paralysis, autonomic dysfunction. Tetanus toxin: Clostridium tetani toxin blocks glycine and GABA release at inhibitory synapses in spinal cord → uncontrolled excitation → spastic paralysis, trismus (lockjaw), risus sardonicus (characteristic facial spasm). Botulinum toxin type A (BOTOX): medical/cosmetic use — injected to temporarily paralyse specific muscles for cosmetic purposes, cervical dystonia, hyperhidrosis, chronic migraine.

An important distinction is between somatic motor control (voluntary) and autonomic control (involuntary) of different muscle types. Somatic motor system: controls skeletal muscle (voluntary). Motor neuron axon → NMJ → ACh → nicotinic receptors → excitatory. One neuron travels from CNS directly to muscle (single synapse). Autonomic nervous system: controls smooth muscle, cardiac muscle, glands (involuntary). Two-neuron chain: preganglionic (CNS to ganglion, ACh at nicotinic receptors) and postganglionic (ganglion to target). Parasympathetic postganglionic: ACh at muscarinic receptors → usually inhibitory (e.g., slows heart, increases GI motility). Sympathetic postganglionic: noradrenaline at adrenergic receptors → usually excitatory for fight-or-flight (exception: sweat glands use ACh). Smooth muscle does not have discrete NMJs like skeletal muscle — instead, autonomic axons release neurotransmitters from varicosities (beaded swellings) distributed along the axon, bathing the smooth muscle cells in neurotransmitter.

The enzyme acetylcholinesterase (AChE), which rapidly terminates ACh signalling by hydrolysing it into inactive products (choline and acetate), is the target of several clinically significant drugs and toxins. Organophosphate insecticides (e.g., malathion, chlorpyrifos) and nerve agents (sarin, VX, soman): irreversibly inhibit AChE → ACh accumulates at all cholinergic synapses → overstimulation of nicotinic and muscarinic receptors → SLUDGE (Salivation, Lacrimation, Urination, Diarrhoea, GI cramping, Emesis) plus muscle fasciculations → seizures → respiratory failure (from excessive secretions + diaphragm paralysis). Atropine (muscarinic antagonist) + pralidoxime (AChE reactivator) are antidotes. Medical uses of AChE inhibitors: Neostigmine/pyridostigmine: treat myasthenia gravis (increases ACh at NMJ, compensating for reduced receptor numbers). Donepezil/rivastigmine/galantamine: treat Alzheimer's disease (increase ACh in cholinergic brain circuits deficient in this disease, temporarily improving cognition).